FMR LLC

Position in LENZ — LENZ Therapeutics, Inc.

CIK 315066 BOSTON, MA

Position in LENZ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,919,722

-$26,323,766 QoQ

Shares Held

3,597,784

-2.8% QoQ

Ownership

11.5%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 99.88907060568394.ToString("F0")% Shared 0.ToString("F0")% None 0.11092939431605678.ToString("F0")%

Healthcare · as of Mar 31, 2026

FMR LLC holds $49,683,576,696 across 351 Biotechnology names. LENZ ranks #111 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	14,579,166	$4,823,808,652
2	ARGX	Argenx SE	4,991,034	$3,644,702,577
3	MRNA	Moderna, Inc.	45,672,024	$2,320,138,818
4	ROIV	Roivant Sciences Ltd.	77,981,253	$2,160,080,705
5	INSM	INSMED Inc	13,160,167	$2,151,950,504
6	IONS	Ionis Pharmaceuticals Inc	24,556,637	$1,843,957,869
7	RPRX	Royalty Pharma plc	25,152,242	$1,206,553,046
8	REGN	Regeneron Pharmaceuticals, Inc.	1,518,192	$1,173,015,865

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,919,722	3,597,784	-2.8%	Shares	Defined	2026-05-15
2025-12-31	$59,243,488	3,702,718	+4140.7%	Shares	Defined	2026-02-17
2025-09-30	$4,067,039	87,313	+7.0%	Shares	Defined	2025-11-13
2025-06-30	$2,392,839	81,639	+0.6%	Shares	Defined	2025-08-14
2025-03-31	$2,086,083	81,139	+38173.1%	Shares	Defined	2025-05-12
2024-12-31	$6,119	212	+58.2%	Shares	Defined	2025-02-13
2024-09-30	$3,181	134	+38.1%	Shares	Defined	2024-11-13
2024-06-30	$1,677	97	-92.9%	Shares	Defined	2024-08-13
2024-03-31	$30,658	1,373	—	Shares	Defined	2024-05-13
No filing history on record for this holder in this stock.